Ovid Therapeutics Inc (FRA:1OT)
€ 1.05 0.04 (3.96%) Market Cap: 77.02 Mil Enterprise Value: 20.38 Mil PE Ratio: 0 PB Ratio: 0.94 GF Score: 34/100

Ovid Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 10, 2021 / 03:00PM GMT
Release Date Price: €3.64 (-0.55%)
Jeremy Max Levin
Ovid Therapeutics Inc. - Chairman & CEO

Good morning. I'm Jeremy Levin, Chairman of the Board of Directors and Chief Executive Officer of Ovid Therapeutics. And it's my great pleasure to welcome you to the company's 2021 Annual Meeting of Stockholders.

It's now 11 a.m., and I'll call this meeting to order and proceed with introductions and formal business of the annual meeting.

I'd like to start off by thanking everybody for joining us today. Please let me introduce to you the members of our senior management team present today: Dr. Amit Rakhit, President and CMO; Mr. Thomas Perone, General Counsel and Corporate Secretary; Mr. Jeff Rona, Chief Business and Financial Officer; Mr. Jason Tardio, Chief Commercial Officer. We're also pleased to introduce the other members of our Board of Directors who joined us today: Ms. Barbara Duncan and Mr. Bart Friedman.

I'd also like to introduce Thomas Klockner, Beth Raposo, Matt Interrante of KPMG LLP, our independent registered public accounting firm, who is available to respond to appropriate questions. And finally,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot